Print
More News

PPD Lands $45.5 Million U.S. Army Contract

By Staff Reports, posted Jun 1, 2011

Wilmington-based pharmaceutical giant PPD has been awarded a lucrative contract by the U.S. Army to support biodefense and vaccine development programs.

The U.S. Army Medical Research contract is a multi-year, indefinite delivery, indefinite quantity contract with a ceiling value of $45.5 million payable over a five-year period.

Under the contract, PPD will provide global regulatory and biostatistical services for a range of drug development initiatives. Currently PPD has offices in 44 countries, giving the company an in-depth knowledge of regulatory requirements worldwide.

PPD will assist the U.S. Army in preparing and filing clinical trial submissions to the U.S. Food and Drug Administration and regulatory authorities in other nations.

To ensure regulatory compliance for clinical programs and to support biodefense, biopreparedness and vaccine development aimed at protecting military personnel, PPD’s research team will work  with its quality assurance and medical writing professionals.

In addition to regulatory strategies and compliance, PPD will also provide statistical consulting, statistical study design and analytical support at every stage of the drug and vaccine development and testing process.

PPD has a history of delivering clinical support services to U.S. government research and development programs. Over the past 21 years, the company has worked on more than 900 government and public health drug development projects. In the past, it has addressed infectious diseases, vaccines, autoimmune and allergic diseases, as well as prior forays into biodefense.

"This contract enables us to deliver on our breadth of global regulatory and biostatistics services and assist the U.S. Army in advancing clinical programs that improve the health of men and women serving in our armed forces," said Henrietta Ukwu, senior vice president of global regulatory affairs for PPD. "We are pleased to partner with the U.S. Army in this effort and to continue to extend our long history of partnering with the U.S. Government on clinical research and development."

Ico insights

INSIGHTS

SPONSORS' CONTENT
Web mcwhorter 0012

Painting The Town -- Blue

Heather McWhorter - UNCW Center for Innovation and Entrepreneurship
Headshotrosaliecalarco 1182131047

When Holiday Shopping With Credit Cards - Pick the Right Plastic

Burrus rob headshot 300x300

Is Humor In Your Leadership Toolbox?

Robert Burrus - Cameron School of Business - UNC-Wilmington

Trending News

Wrightsville Beach Oceanfront Home Sale Tops May Record

Cece Nunn - Dec 1, 2021

Chamber Releases Economic Scorecard on Wilmington Region 

Johanna F. Still - Dec 1, 2021

Development Proposal Plants Commercial Space On Farm Land

Cece Nunn - Dec 3, 2021

Soup's On At New Asian Restaurant In Porters Neck

Jenny Callison - Dec 1, 2021

With Listening Sessions Complete, New Hanover Endowment Looks Ahead

Johanna F. Still - Dec 2, 2021

In The Current Issue

Seniors Find Health, Friends In Fitness

If there’s one word to describe the members of Sandy Sneakers, an exercise group for seniors, it’s “vivacious.” They have the energy of a 30...


Chain Reaction: Coping With A Disrupted Supply Chain

The worldwide supply chain disruption is a perfect storm, said Drew Rosen, professor of supply chain management at the University of North C...


Employers Monitor Vaccine Rules

With judicial review underway on the Biden administration’s vaccination mandate for businesses with 100 or more employees, leading employers...

Book On Business

The 2021 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

Trying to Grow a Business?
2020 Health Care Heroes
2020 WilmingtonBiz 100